Editors' Picks
Profluent Achieves Human Genome Editing Milestone Using OpenCRISPR-1: The First AI-Generated, Open-Source Gene Editor
2024-05-08
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
Scientists at the University of California, Riverside (UC Riverside) have recently unveiled a groundbreaking RNA-based vaccine strategy that could revolutionize vaccination efforts against a myriad …
2024-05-02
Special
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
[Taipei, Taiwan; May 1, 2024] – Taiwan took a significant leap in healthcare advancements as the nation’s National Health Insurance (NHI) officially integrated next-generation sequencing …
2024-05-02
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
Dr. Remi Shih, Thoa Nong, Dr. Jar-How Lee and their team at the Terasaki Innovation Center in California have recently discovered novel mechanisms behind allograft …
Mechanisms of Allograft Rejection: Insights from Behind the Scenes Read More »
2024-04-25
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
As Earth Day garners increased attention towards environmental concerns, hospitals find themselves under greater scrutiny for their contribution to waste and pollution. With nurses and …
Earth Day Awareness: Hospitals Embrace Sustainability Efforts Read More »
2024-04-22
LATEST
Revolutionizing Treatment: ASGCT’s Clinical Trials Spotlight on Immunotherapy, Cancer Vaccines, and Auditory Diseases
2024-05-09
Advancing Health: ASGCT’s Clinical Trials Spotlight on Cell Therapy and Cell-Based Gene Therapy
2024-05-09
Infinitopes’ Article in Peer-Reviewed Journal Seeks to Unlock the Potential of Cancer Vaccines
2024-05-09
Profluent Achieves Human Genome Editing Milestone Using OpenCRISPR-1: The First AI-Generated, Open-Source Gene Editor
2024-05-08
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06